The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1 (original) (raw)

• Faccio, L. et al. Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J. Biol. Chem. 275, 2581–2588 (2000).
  Article CAS Google Scholar
• Gray, C. W. et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. 267, 5699–5710 (2000).
  Article CAS Google Scholar
• Hegde, R. et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein–caspase interaction. J. Biol. Chem. 277, 432–438 (2002).
  Article CAS Google Scholar
• Martins, L. M. et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277, 439–444 (2002).
  Article CAS Google Scholar
• Suzuki, Y. et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613–621 (2001).
  Article CAS Google Scholar
• Verhagen, A. M. et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 277, 445–454 (2002).
  Article CAS Google Scholar
• Martins, L. M. et al. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J. Biol. Chem. 278, 49417–49427 (2003).
  Article CAS Google Scholar
• Yang, Q. H., Church-Hajduk, R., Ren, J., Newton, M. L. & Du, C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev. 17, 1487–1496 (2003).
  Article CAS Google Scholar
• Jones, J. M. et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425, 721–727 (2003).
  Article CAS Google Scholar
• Martins, L. M. et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24, 9848–9862 (2004).
  Article CAS Google Scholar
• Spiess, C., Beil, A. & Ehrmann, M. A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 97, 339–347 (1999).
  Article CAS Google Scholar
• Walsh, N. P., Alba, B. M., Bose, B., Gross, C. A. & Sauer, R. T. OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain. Cell 113, 61–71 (2003).
  Article CAS Google Scholar
• Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099–2111 (2005).
  Article CAS Google Scholar
• Cilenti, L. et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 279, 50295–50301 (2004).
  Article CAS Google Scholar
• Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160 (2004).
  Article CAS Google Scholar
• Bonifati, V. et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65, 87–95 (2005).
  Article CAS Google Scholar
• Hatano, Y. et al. Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 56, 424–427 (2004).
  Article CAS Google Scholar
• Li, Y. et al. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism. Neurology 64, 1955–1957 (2005).
  Article CAS Google Scholar
• Rogaeva, E. et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch. Neurol. 61, 1898–1904 (2004).
  Article Google Scholar
• Rohe, C. F. et al. Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann. Neurol. 56, 427–431 (2004).
  Article CAS Google Scholar
• Obenauer, J. C., Cantley, L. C. & Yaffe, M. B. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635–3641 (2003).
  Article CAS Google Scholar
• Kuma, Y. et al. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J. Biol. Chem. 280, 19472–19479 (2005).
  Article CAS Google Scholar
• Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 11715–11720 (1998).
  Article CAS Google Scholar
• Li, W. et al. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nature Struct. Biol. 9, 436–441 (2002).
  Article CAS Google Scholar
• Wilken, C., Kitzing, K., Kurzbauer, R., Ehrmann, M. & Clausen, T. Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease. Cell 117, 483–494 (2004).
  Article CAS Google Scholar
• Greenamyre, J. T. & Hastings, T. G. Biomedicine. Parkinson's—divergent causes, convergent mechanisms. Science 304, 1120–1122 (2004).
  Article CAS Google Scholar
• Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595–600 (2004).
  Article CAS Google Scholar
• Ramirez, A. et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nature Genet. 38, 1184–1191 (2006).
  Article CAS Google Scholar
• Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601–607 (2004).
  Article CAS Google Scholar
• Beilina, A. et al. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA 102, 5703–5708 (2005).
  Article CAS Google Scholar
• Silvestri, L. et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477–3492 (2005).
  Article CAS Google Scholar
• Sim, C. H. et al. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Mol. Genet. 15, 3251–3262 (2006).
  Article CAS Google Scholar
• Harper, S. J. & Wilkie, N. MAPKs: new targets for neurodegeneration. Expert Opin. Ther. Targets 7, 187–200 (2003).
  Article CAS Google Scholar
• Pridgeon, J. W., Olzmann, J. A., Chin, L. S. & Li, L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLOS Biol. 5, e172 (2007).
  Article Google Scholar
• Young, J. C. & Hartl, F. U. A stress sensor for the bacterial periplasm. Cell 113, 1–2 (2003).
  Article CAS Google Scholar
• Abou-Sleiman, P. M. et al. A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann. Neurol. 60, 414–419 (2006).
  Article CAS Google Scholar
• Gandhi, S. et al. PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720–1731 (2006).
  Article CAS Google Scholar
• Vyas, S. et al. Differentiation-dependent sensitivity to apoptogenic factors in PC12 cells. J. Biol. Chem. 279, 30983–30993 (2004).
  Article CAS Google Scholar
• Evan, G. I., Lewis, G. K., Ramsay, G. & Bishop, J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5, 3610–3616 (1985).
  Article CAS Google Scholar
• Garner, A. P., Weston, C. R., Todd, D. E., Balmanno, K. & Cook, S. J. ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint. Oncogene 21, 8089–8104 (2002).
  Article CAS Google Scholar
• Rytomaa, M., Lehmann, K. & Downward, J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 19, 4461–4468 (2000).
  Article CAS Google Scholar
• Abraham, V. C., Taylor, D. L. & Haskins, J. R. High content screening applied to large-scale cell biology. Trends Biotechnol. 22, 15–22 (2004).
  Article CAS Google Scholar